WO2002051810A3 - Ligands des recepteurs des integrines - Google Patents
Ligands des recepteurs des integrines Download PDFInfo
- Publication number
- WO2002051810A3 WO2002051810A3 PCT/EP2001/014924 EP0114924W WO02051810A3 WO 2002051810 A3 WO2002051810 A3 WO 2002051810A3 EP 0114924 W EP0114924 W EP 0114924W WO 02051810 A3 WO02051810 A3 WO 02051810A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- integrin receptor
- receptor ligands
- ligands
- integrin
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10064823.1 | 2000-12-22 | ||
DE10064823A DE10064823A1 (de) | 2000-12-22 | 2000-12-22 | Integrinrezeptorliganden |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002051810A2 WO2002051810A2 (fr) | 2002-07-04 |
WO2002051810A3 true WO2002051810A3 (fr) | 2003-03-20 |
Family
ID=7668842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/014924 WO2002051810A2 (fr) | 2000-12-22 | 2001-12-18 | Ligands des recepteurs des integrines |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE10064823A1 (fr) |
WO (1) | WO2002051810A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101204247B1 (ko) | 2003-07-22 | 2012-11-22 | 아스텍스 테라퓨틱스 리미티드 | 3,4-이치환된 1h-피라졸 화합물 및 그의 시클린 의존성키나제 (cdk) 및 글리코겐 합성효소 키나제-3(gsk-3) 조정제로서 용도 |
AR047894A1 (es) | 2004-02-25 | 2006-03-01 | Wyeth Corp | Derivados de tiofeno como inhibidores de la proteina tirosina fosfatasa 1b (ptpasa 1b); metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por ptpasa 1b |
AR054425A1 (es) | 2005-01-21 | 2007-06-27 | Astex Therapeutics Ltd | Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico. |
US8404718B2 (en) | 2005-01-21 | 2013-03-26 | Astex Therapeutics Limited | Combinations of pyrazole kinase inhibitors |
US8329703B2 (en) | 2005-02-15 | 2012-12-11 | Xtl Biopharmaceuticals Ltd. | Pyrazole compounds |
JP2010506843A (ja) | 2006-10-13 | 2010-03-04 | エックスティーエル バイオファーマシューティカルズ リミテッド | Hcvを治療するための化合物および方法 |
KR20200030584A (ko) | 2017-07-21 | 2020-03-20 | 앤타바이오 에스에이에스 | 화합물 |
JP7429799B2 (ja) | 2020-02-18 | 2024-02-08 | ギリアード サイエンシーズ, インコーポレイテッド | 抗ウイルス化合物 |
TWI775313B (zh) | 2020-02-18 | 2022-08-21 | 美商基利科學股份有限公司 | 抗病毒化合物 |
TW202322824A (zh) | 2020-02-18 | 2023-06-16 | 美商基利科學股份有限公司 | 抗病毒化合物 |
EP4323362A1 (fr) | 2021-04-16 | 2024-02-21 | Gilead Sciences, Inc. | Procédés de préparation de carbanucléosides à l'aide d'amides |
US12116380B2 (en) | 2021-08-18 | 2024-10-15 | Gilead Sciences, Inc. | Phospholipid compounds and methods of making and using the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997036862A1 (fr) * | 1996-03-29 | 1997-10-09 | G.D. Searle & Co. | DERIVES DE PHENYLENE META-SUBSTITUES, UTILISES COMME ANTAGONISTES OU INHIBITEURS DE L'INTEGRINE ALPHAvBETA¿3? |
WO2000009503A1 (fr) * | 1998-08-13 | 2000-02-24 | Merck & Co., Inc. | Antagonistes de recepteurs d'integrine |
-
2000
- 2000-12-22 DE DE10064823A patent/DE10064823A1/de not_active Withdrawn
-
2001
- 2001-12-18 WO PCT/EP2001/014924 patent/WO2002051810A2/fr not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997036862A1 (fr) * | 1996-03-29 | 1997-10-09 | G.D. Searle & Co. | DERIVES DE PHENYLENE META-SUBSTITUES, UTILISES COMME ANTAGONISTES OU INHIBITEURS DE L'INTEGRINE ALPHAvBETA¿3? |
WO2000009503A1 (fr) * | 1998-08-13 | 2000-02-24 | Merck & Co., Inc. | Antagonistes de recepteurs d'integrine |
Also Published As
Publication number | Publication date |
---|---|
DE10064823A1 (de) | 2002-06-27 |
WO2002051810A2 (fr) | 2002-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0200803A3 (en) | Substituted bicyclic heteroaryl compounds as integrin antagonists, pharmaceutical compositions containing them and the intermediates | |
WO2003084943A3 (fr) | Derives de terphenyle, leur preparation, les compositions pharmaceutiques en contenant | |
BR0209242A (pt) | Aminopolidiorganossiloxanos amido-funcionais | |
AP2003002916A0 (en) | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis. | |
WO2001032646A3 (fr) | Nouveaux composes | |
HK1055955A1 (en) | Methanesulphonamido-benzofuran, preparation methodand use thereof as synthesis intermediate. | |
IL150225A0 (en) | Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof | |
HUP0203108A3 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
AU2001241056A1 (en) | Spiro compounds, process for preparing the same and use thereof as drugs | |
WO2002051810A3 (fr) | Ligands des recepteurs des integrines | |
MY135916A (en) | Use of certain affinity nmda antagonists as antidepressants | |
IL149427A0 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
MXPA03007635A (es) | P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen. | |
HUP0201571A3 (en) | Il-8 receptor antagonist phenyl urea derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
HK1052007A1 (en) | Novel heterocyclic derivatives, preparation methodand pharmaceutical compositions containing same. | |
ZA200201521B (en) | Alkoxy substituted benzimidazole compounds, pharmaceutical preparation containing the same, and methods of using the same. | |
WO2003039456A3 (fr) | Procede de preparation de ligands de recepteurs de la thyroide derives d'aniline | |
DK1958938T3 (da) | Fremgangsmåde til fremstilling af 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid | |
HK1045684A1 (en) | Biphenyl derivatives as antagonists of the neurokinine-1 receptor. | |
WO2000061551A3 (fr) | Ligands de recepteurs d'integrine | |
WO2003097597A3 (fr) | Derives d'indole et leur utilisation en tant que ligands des recepteurs cb2 | |
HUP0300928A3 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
MXPA02012015A (es) | Ligandos de receptores para integrinas. | |
HUP0303804A3 (en) | Ligands of the avss6 integrin, process for their preparation, their use and pharmaceutical compositions containing them | |
AU4543200A (en) | Pharmaceutical or cosmetic compositions for the local, intradermal application of hormones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |